Delving into the Latest Updates on GMPack ApS with Synapse

Overview

主要目的：研究单次（2g）和多次口服（2 x 2g）欧米加-3-酸乙酯90软胶囊（Omacor）后，ω-3-脂肪酸乙酯在中国健康男性和女性受试者中的药代动力学次要目的：研究单次和多次口服欧米加-3-酸乙酯90软胶囊（Omacor）后的安全性和耐受性

[Translation]

Primary objective: To investigate the pharmacokinetics of omega-3 fatty acid ethyl esters in healthy Chinese male and female subjects after single (2 g) and multiple oral doses (2 x 2 g) of omega-3-acid ethyl ester 90 soft capsules (Omacor) Secondary objective: To investigate the safety and tolerability of omega-3-acid ethyl ester 90 soft capsules (Omacor) after single and multiple oral doses

Start Date30 Jun 2017

Sponsor / Collaborator

AbbVie Pharmaceuticals GmbH

[+3]

100 Clinical Results associated with GMPack ApS

Login to view more data

0 Patents (Medical) associated with GMPack ApS

Login to view more data

100 Deals associated with GMPack ApS

Login to view more data

100 Translational Medicine associated with GMPack ApS

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 06 Mar 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data